Background/Aims: Mesenchymal stromal cells (MSCs) participate in the tissue-specific repair of many different organs, especially the kidney. Their effects are primarily mediated by the paracrine release of factors including extracellular vesicles (EVs), which are composed of micro-vesicles and exosomes. The corresponding microRNAs (miRNAs) of EVs are considered important for their biological functions. Methods: MSCs were cultured from the human umbilical cord, and EVs were isolated from the medium. The expression levels of miRNAs in MSCs and EVs were determined by microarray analysis, and gene ontology (GO) was used to analyze the functions of their target genes. Results: MSCs and EVs had similar miRNA expression profiles, with the exception of a small number of selectively enriched miRNAs. GO analysis indicated that, unlike MSCs, the target genes of EV-enriched miRNAs were associated with calcium channel regulation and cell junction activities, which may indicate that MSC and EVs have different regulatory properties. Angiogenesis, oxidative stress, and inflammatory signaling pathways related to the repair of renal injury were also analyzed, and EV-enriched miRNAs targeted genes associated with oxidative stress, T cell activation, and Toll-like receptor signaling. The miRNAs enriched in both MSCs and EVs targeted different genes in signaling pathways regulating angiogenesis and chemokine release. Conclusion: MSCs and their EVs shared similar miRNA component, and some selectively enriched miRNAs observed in MSCs and EVs may affect different target genes through some specific signaling pathways.
Introduction
Mesenchymal stromal cells (MSCs) comprise a heterogeneous population of cells with self-renewal ability. They are derived from various tissues and are considered important for regenerative medicine applications as they orchestrate regenerative wound healing and the tissue-specific repair of many different organs, especially the kidney [1, 2] . Although a considerable number of experiments have shown that MSCs are safe [3] , their ability to promote the proliferation of some types of tumor cells and the lack of long-term observational studies have raised concerns regarding their clinical use.
Extracellular vesicles (EVs) are membrane-bound vesicles that are secreted by cells into the circulatory system. They contain functional proteins and RNAs from the original cells. Importantly, the effects of MSCs are primarily via the release of factors including EVs; thus, EVs may exhibit some MSC-like properties in tissue repair, and their low immunogenicity has made them a good alternative to cell therapy [4] . In our previous study, we demonstrated that human umbilical cord-derived MSCs (huMSCs) have therapeutic effects in alleviating acute and chronic kidney injury via an endocrine mechanism [2] . In addition, huMSC-derived EVs also exhibit therapeutic effects in the repair of kidney injury. Furthermore, Nargesi et al. have confirmed the therapeutic effects of MSC-derived EVs in a kidney injury model as well as the underlying mechanisms [5] . It has also been shown that RNAs, especially microRNAs (miRNAs), play key roles in kidney injury repair, and the main RNAs in EVs are miRNAs [6] [7] [8] . Thus a comprehensive analysis of the miRNAs in MSCs and EVs would facilitate a better understanding of the molecular mechanisms and therapeutic potential of MSC-derived EVs.
In this study, we used microarray analysis to compare the expression of miRNAs in MSCs and EVs, especially in aspects of kidney injury repair to build a better understanding of the molecular mechanism for EV treatment.
Materials and Methods

Ethics Statement
All studies involving human participants were approved by the Research Ethics Committee of Shanghai Jiao Tong University (Shanghai, China). All human subjects provided written informed consent for their participation in the study and publication of the case details.
Cell culture and EV isolation
HuMSCs were isolated as previously described [2] . Briefly, the umbilical cords were cut into small pieces, and then allowed to stick to the bottom of the cell culture plates. Dulbecco's Modified Eagle's Medium (DMEM) Low Glucose (Gibco, Gaithersburg, MD, USA) with 10% fetal bovine serum was added to the cells, The cells expressed MSCs markers (i.e., Cluster of Differentiation 44 [CD44], CD73, CD90, CD105), but not hematopoietic or endothelial markers, and were able to differentiate into chondrocytes and osteoblasts [2] . The isolated cells met the minimal criteria included in the definition of MSCs issued by the International Society of Cellular Therapy [3] . All cells used in our experiments were from early passages 3 to 6. EVs were acquired from the condition medium used to culture MSCs as previously described [7] . Briefly, DMEM Low Glucose was added to the cells followed by an overnight incubation. Condition medium was collected and centrifuged at 2000 x g to remove the cell debris, and then centrifuged again at a speed of 100, 000 x g for 1 h at 4°C to acquire the EVs. The cells were trypan blue-negative, and the terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) test was done after collecting the condition medium. EVs acquired the MSC cell surface markers CD90, CD44, and CD105, and the exosome markers CD81 and CD9.
MiRNA microarray analysis
The Qiagen RNA isolation kit was used to extract total RNA, which was analyzed using the Agilent 2100 Bioanalyzer (Agilent Technologies, Savage, MD, USA) as previously described [7] . The miRCURY TM Array Power Labeling Kit (No. 208032-A; Exiqon, Vedbaek, Denmark) was used for miRNA labeling, the Axon GennePix 4000B Microarray Scanner (Molecular Devices, Dowingtown, PA, USA) was used for scanning, and GenePix Pro version 6.0 was used for analysis. Different levels of miRNA expression (normalized) in EVs and MSCs were calculated with fold-change >1. 4 and P values <0.05 (Student's t-test). Target Scan (version 7.1) was used to predict the target genes of miRNAs enriched in MSCs and EVs. All genes with a target prediction score ≥80 were subjected to gene ontology (GO) analysis using the protein analysis through evolutionary relationships (PANTHER) classification system.
Results
miRNA expression
MSCs and EVs expressed similar amounts of miRNA (n=2089). Only 0.8% (16/2089) and 0.9% (19/2089) of miRNAs were enriched in MSCs and EVs, respectively (Fig. 1) . The different enriched miRNAs in MSCs and EVs are also listed (P<0.05, Fold Change ≥1.4, n=3) (Fig. 2) .
Functional analysis of enriched miRNAs
We predicted the target genes of miRNAs enriched in MSCs and EVs. A total of 16 miRNAs were enriched in MSCs and 147 target genes had a prediction score >80, and 19 miRNAs were enriched in EVs with 367 target genes. Molecular function analyses showed that the miRNAs enriched in MSCs or EVs were involved in binding, catalytic activity, receptor activity, signal transducer activity, or structural molecule activity (Fig. 3) . Cellular component analyses showed that these genes mainly participated in cell parts, organelles, or macromolecular complexes. However, unlike MSCs, EV-enriched miRNAs regulated voltagedependent calcium channels and cell junction functions (SMPX: small muscular protein, ZYX: Zyxin, MPP2: membrane protein palmitoylated 2).
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Pathway analysis of selective enriched miRNAs
Several selectively miRNAs enriched in MSCs (Fig. 4) and EVs (Fig. 5) were found to be involved in the regulation of various pathways. MSC-enriched miRNAs participate in axon guidance mediated by semaphorins, the circadian clock system, cytoskeletal regulation by Rho GTPase, de novo purine biosynthesis, endogenous cannabinoid signaling, and pyrimidine metabolism (Table 1) . EV-enriched miRNAs participate in adrenaline and noradrenaline biosynthesis, dopamine receptor-mediated signaling pathways, enkephalin release, the oxidative stress response, Parkinson's disease, the pyridoxal phosphate salvage pathway, pyridoxal-5-phosphate biosynthesis, synaptic vesicle trafficking, T cell activation, tricarboxylic acid cycle, toll-like receptor signaling, vitamin B6 metabolism, the vitamin D metabolic pathway, mRNA splicing, and the p38 mitogen-activated protein kinase pathway.
Gene analysis in renal injury repair pathways
Angiogenesis, oxidative stress, and inflammation signals play key roles in tissue injury repair. Both MSCs and EVs expressed miRNAs that target different genes in angiogenesis and inflammation mediated by chemokine and cytokine signaling pathways. Moreover, EVenriched miRNAs are also involved with several genes associated with oxidative stress, T cell activation, and the transforming growth factor beta signaling and toll-like receptor signaling pathways ( Table 2) .
Discussion
In this study, we compared the miRNA content of huMSCs and EVs for a better understanding of the therapeutic potential of EVs. Our results showed that EVs had a similar miRNA expression profile as MSCs, with the exception of a small proportion of selectively enriched miRNAs. GO analysis indicated the involvement of EV-enriched miRNAs in some specific functions such as ion channel regulation (calcium channel activity), oxidative function, and inflammation regulatory properties, which lays the basic foundation for cell replacement therapy involving EV for tissue injury repair.
MSCs have been widely used in various types of tissue injury repair, such as myocardial and renal injury, and paracrine effects play key roles. EVs are secreted by MSCs and are present in the original cell. A large amount of evidence has indicated that MSC-derived EVs can alleviate both acute and chronic kidney injury and preserve renal function, which has led to cell-free treatment in renal injury repair [5] . RNAs expressed in EVs are regarded as the most functional elements of renal injury repair, and the main RNAs in huMSC-derived EVs are miRNAs [7] . Microarray analysis showed that EVs had miRNA contents similar to those of their original cells, indicative of their strong therapeutic potential.
We also compared the different levels of miRNA expression in MSCs and EVs, and found only a few enriched miRNAs. Molecular function analysis revealed that EV-enriched miRNA showed specific calcium channel regulator activity not found in their MSC-enriched counterparts. Various calcium channel subtypes are expressed in the renal arterioles and tubules, and these channels are important for the regulation of renal blood flow [9] . Clinically, calcium channel blockers have been widely used in patients with renal disease due to high blood pressure, and calcium channel blockade facilitates renal injury repair [10, 11] . In this study, cellular component analysis showed that EV-enriched miRNAs target specific cell junction-related proteins such as SMPX, Zyxin, and MPP2. Zyxin has functions in cellmatrix interactions and the transmission of signals from the cytoplasm to the nucleus. It is also involved in renal epithelial differentiation and morphogenesis [12] . Thus, compared to MSCs, EVs may exist prior regulatory properties in these cellular pathways. Complicated physiological and pathological processes are involved in the repair of renal injury repair. Peritubular capillary rarefaction is a typical feature in chronic renal disease and methods that restore microvasculature help protect renal functions [13, 14] . MSCs play vascular trophic roles in renal repair after ischemic injury [15] , and EVs enhance microvascular density after renal injury [16] . It has been reported that activation of endothelium Notch1 leads to renal capillary rarefaction along with fibrosis [17] . In this study, angiogenesis pathway analysis indicated that MSC-enriched miRNAs targeted Notch1, PRKCB, CRK, and FZD3 genes, and EV-enriched miRNAs targeted DVL-3, HRAS, PRKCA, and WNT7α pathways, which showed the differences among regulatory genes in the angiogenesis pathway. Oxidative stress is another important factor in renal injury repair, especially in ischemic reperfusion-induced acute kidney injury [18] . The regulation of oxidative stress by MSCs and EVs has been widely reported in renal injury repair [19, 20] . Here, we found that EVs show showed more potency in oxidative stress pathways related to the DUSSP8 and MKNK2 genes than MSCs, as indicated by miRNA levels. MSCs have potent inflammation regulatory properties in renal diseases [1] . The activation of T cells plays a role in renal injury repair, which involves regulatory T cells (Tregs), natural killer T cells, and others. MSCs attenuate cisplatin and ischemia-induced acute kidney injury by elevating levels of Tregs in injured kidneys [21, 22] . MSC-EVs affect T cell populations in renal allograft rats [23] . Gene analysis has shown that EV-enriched miRNAs target HRAS and CD3G, which are genes related to T cell activation, indicating that EVs have better T cell activity regulatory properties than MSCs. Toll-like receptors are involved in the inflammatory effects of renal injury [24, 25] , and are also target genes for renal therapy. EV-enriched miRNAs target TAB1, which suggests that they may regulate the toll-like receptor signaling pathway.
Acquiring functional EVs by target cells is the basic step required for EV therapy, and the whole secretome of MSCs is modified by senescence [26] . The contents of EVs may differ depending on the passage of its original cells. Indeed, miR203a-2p was found in our isolated EVs, and may regulate protein deglycase DJ-1 in senescent cells. However, in light of the limited passages of cells used in this study, senescence-related proteins and mRNAs in EVs from different passages of MSCs should be studied in future experiments to for further confirmation of our results.
Different enriched miRNAs in huMSCs and EVs were found in this work and several renal injury repair-related genes were also analyzed. However, this work also had some limitations. Microarray experiments are often restricted by the number of samples; thus additional experiments should be performed to confirm our findings. The MSCs and EVs in this work expressed their own repertoires of enriched miRNAs with target genes that affect different pathways involved in renal injury repair. Further experiments should be performed on tissues treated with MSCs and EVs.
Conclusion
MSCs and the EVs they secrete share similar miRNA contents, which indicate the potential therapeutic functions of EVs. Some selectively enriched miRNAs observed in MSCs, EVs, or both may affect different target genes through specific signaling pathways, suggesting their different implications for therapy. These observations provide a theoretical basis for tissue injury repair by MSC-derived EVs for future clinical treatment.
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